APP and neoplasm: Similarly, tumor-cell-derived amyloid precursor protein (APP) can activate the RIPK1-RIPK3-MLKL axis-induced necroptosis through binding to death receptor 6 (DR6) in endothelial cells, which enhances the extravasation of circulating tumor cells (CTCs) [52,53].